<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00662428</url>
  </required_header>
  <id_info>
    <org_study_id>BÄK 06-69</org_study_id>
    <nct_id>NCT00662428</nct_id>
  </id_info>
  <brief_title>Increasing Cost-effectiveness of Inpatient Treatment of Affective Disorders</brief_title>
  <acronym>INCA</acronym>
  <official_title>Evaluation of a Guideline-based Net Care Intervention to Reduce the Duration of Inpatient Depression Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Medical Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Freiburg</source>
  <brief_summary>
    <textblock>
      The cost-effectiveness of a new, guideline oriented sequential inpatient - outpatient&#xD;
      treatment model will be investigated. Secondary outcomes are: patient satisfaction,&#xD;
      practitioners' satisfaction and influence on work.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Great diversity concerning duration of inpatient treatment of depression in&#xD;
      psychiatric-psychotherapeutic hospitals is often used as an argument for the possible&#xD;
      reduction of length of stay. Yet shorter duration of inpatient treatment of depressive&#xD;
      episodes has not been examined systematically concerning clinical outcomes and health&#xD;
      economic consequences. In this study the cost-effectiveness of a new sequential&#xD;
      inpatient-outpatient treatment model will be examined. The research hypothesis is that the&#xD;
      new treatment model will be more cost-effective than treatment as usual. The design provides&#xD;
      a randomized controlled trial (RCT) in four psychiatric-psychotherapeutic clinics with a&#xD;
      total of 240 patients. First medical practitioners and psychologist will receive a retraining&#xD;
      concerning guideline-based care and the new treatment model will be implemented in the&#xD;
      hospitals. New patients admitted to one of the hospitals will then be assigned randomly to&#xD;
      one of the two study conditions und prospectively examined at five measuring times: Condition&#xD;
      A (control group) contains treatment as usual (individual treatment programme, discharge&#xD;
      after remission), Condition B (intervention group) contains the sequential&#xD;
      inpatient-outpatient treatment (guideline-based treatment, discharge after partly remission:&#xD;
      BDI &lt;20, outpatient treatment in the hospital and guided transfer to outpatient care).&#xD;
&#xD;
      Primary outcome is the reduction of costs of treatment in relation to reduction of symptoms.&#xD;
      Secondary outcomes will be reduction of the depressive pathology as well as the extent of&#xD;
      satisfaction among patients and practitioners. A total of 240 patients will be examined from&#xD;
      admission until 12 month after discharge. Both information from the patients and the&#xD;
      practitioners will be charged with well implemented and established instruments (psychiatric&#xD;
      basic documentation system, BADO). A specific questionnaire will be used to measure the&#xD;
      practitioners' satisfaction and the consequences of the sequential inpatient-outpatient&#xD;
      treatment. To answer the main question about the cost-effectiveness analyses of central&#xD;
      health economic outcome variables (direct and indirect costs of treatment) will be performed.&#xD;
      This study is going to give differentiated and scientific evidence of the efficiency of a new&#xD;
      sequential inpatient-outpatient treatment for depressive disorders. The participation of&#xD;
      psychiatric-psychotherapeutic hospitals with different functions and structures in the public&#xD;
      health care systems (academic medical centre, psychiatric department of general hospital,&#xD;
      psychiatric centres) enable the evaluation of the new treatment model under diverse&#xD;
      structural and organizational conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cost-effectiveness: ratio of treatment response and treatment costs</measure>
    <time_frame>one year after discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom reduction</measure>
    <time_frame>at discharge, 6 month after discharge, and one year after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>at discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">202</enrollment>
  <condition>Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Symptom based discharge management</intervention_name>
    <description>Depressive symptoms of patients are weekly assessed by Beck Depression Inventory (BDI II). Patients are discharged when BDI-score is under 20 points. Patients are treated in the same hospital for two more weeks as outpatients before being referred to outpatient care (general practitioner or specialist).</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment as usual</intervention_name>
    <description>Treatment as usual is the usual stationary depression treatment which consists of a combination of several psychopharmacological and psychotherapeutical treatments. Duration of treatment is varying widely.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current depressive episode at time of admission&#xD;
&#xD;
          -  ICD-10 diagnosis:&#xD;
&#xD;
               -  Depressive episode, F 32.xx&#xD;
&#xD;
               -  Recurrent depressive episode, F 33.xx&#xD;
&#xD;
          -  Depression is primary treatment indication&#xD;
&#xD;
          -  The ability to give informed consent&#xD;
&#xD;
          -  Sufficient German language skills&#xD;
&#xD;
          -  Being resident sufficiently close to the hospital for being able to take part in the&#xD;
             outpatient program&#xD;
&#xD;
          -  permanent residence&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Alcohol or drug dependence (not misuse)&#xD;
&#xD;
          -  Psychotic symptoms&#xD;
&#xD;
          -  Schizoaffective disorders&#xD;
&#xD;
          -  Bipolar disorders&#xD;
&#xD;
          -  Schizophrenia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Härter, Prof. Dr. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isaac Bermejo, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars P Hölzel, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Krankenhaus Hofheim</name>
      <address>
        <city>Hofheim</city>
        <state>Hessen</state>
        <zip>65719</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bezirkskrankenhaus Bayreuth</name>
      <address>
        <city>Bayreuth</city>
        <zip>D-95445</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Freiburg University Medical Center, Dept. of Psychiatry and Psychotherapy</name>
      <address>
        <city>Freiburg</city>
        <zip>D-79104</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>D-76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum am Weissenhof</name>
      <address>
        <city>Weinsberg</city>
        <zip>D-74189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Hölzel L.P., Bermejo I. &amp; Härter M. (2011). Geordnetes Entlassmanagement - Bewertung eines neuen Behandlungsmodells zur Verkürzung der Verweildauer bei depressiven Erkrankungen. Deutsches Ärzteblatt, 108, 1050-1051.</citation>
  </results_reference>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>April 15, 2008</study_first_submitted>
  <study_first_submitted_qc>April 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2008</study_first_posted>
  <last_update_submitted>June 20, 2012</last_update_submitted>
  <last_update_submitted_qc>June 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Freiburg</investigator_affiliation>
    <investigator_full_name>Martin Härter</investigator_full_name>
    <investigator_title>Prof. Dr. Dr.</investigator_title>
  </responsible_party>
  <keyword>cost-benefit analysis</keyword>
  <keyword>practice guideline</keyword>
  <keyword>inpatients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

